The Food and Drug Administration (FDA) has issued a warning to the public about the potential health risks of cannabis products containing delta-8 THC. The FDA is concerned about the proliferation of these products, which are being marketed without approval for therapeutic or medical uses. This practice is considered misleading and violates federal law, putting consumers at risk. Adverse events associated with delta-8 THC include hallucinations, vomiting, tremors, anxiety, dizziness, confusion, and loss of consciousness.
It is important for consumers to be aware of these products and their potential health risks as more and more different types continue to proliferate in the market. Melanie Padgett Powers is a freelance writer and editor specializing in health care and public health. She is also part of the UCLA Cannabis Research Initiative, which studies the health aspects of cannabis products and educates the public. Consumers should be aware that cannabis products containing delta-8 THC may pose serious health risks.
It is important to consult with a healthcare professional before using any cannabis product, as they can provide advice on the potential risks and benefits.
